Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery

被引：119
|
作者：
Guckenberger, Matthias [1 ]
Baus, Wolfgang W. [2 ]
Blanck, Oliver [3 ]
Combs, Stephanie E. [4 ]
Debus, Juergen [5 ]
Engenhart-Cabillic, Rita [6 ]
Gauer, Tobias [7 ]
Grosu, Anca L. [8 ]
Schmitt, Daniela [5 ]
Tanadini-Lang, Stephanie [1 ]
Moustakis, Christos [9 ]
机构：
[1] Univ Zurich, Univ Spital Zurich, Klin Radioonkol, Zurich, Switzerland
[2] Univ Klinikum Koln, Klin Radioonkol & Strahlentherapie, Cologne, Germany
[3] Univ Klinikum Schleswig Holstein, Klin Strahlentherapie, Kiel, Germany
[4] Tech Univ Munich, Klinikum Rechts Isar, Klin Radioonkol & Strahlentherapie, Munich, Germany
[5] Univ Klinikum Heidelberg, Klin Radioonkol & Strahlentherapie, Heidelberg, Germany
[6] Univ Klinikum Giessen Marburg, Klin Strahlentherapie & Radioonkol, Marburg, Germany
[7] Univ Klinikum Hamburg Eppendorf, Klin Strahlentherapie & Radioonkol, Hamburg, Germany
[8] Univ Klinikum Freiburg, Klin Strahlenheilkunde, Robert Koch Str 3, D-79106 Freiburg, Germany
[9] Univ Klinikum Munster, Klin Strahlentherapie, Munster, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2020年 / 196卷 / 05期
关键词：
Radiosurgery; Stereotactic Body Radiotherapy; SRS; SBRT; Definition; BODY RADIOTHERAPY; PRINCIPLES;
D O I：
10.1007/s00066-020-01603-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Stereotactic radiotherapy with its forms of intracranial stereotactic radiosurgery (SRS), intracranial fractionated stereotactic radiotherapy (FSRT) and stereotactic body radiotherapy (SBRT) is today a guideline-recommended treatment for malignant or benign tumors as well as neurological or vascular functional disorders. The working groups for radiosurgery and stereotactic radiotherapy of the German Society for Radiation Oncology (DEGRO) and for physics and technology in stereotactic radiotherapy of the German Society for Medical Physics (DGMP) have established a consensus statement about the definition and minimal quality requirements for stereotactic radiotherapy to achieve best clinical outcome and treatment quality in the implementation into routine clinical practice.
引用
收藏
页码：417 / 420
页数：4
相关论文
共 34 条
  • [31] Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study
    Hurkmans, Coen W.
    Cuijpers, Johan P.
    Lagerwaard, Frank J.
    Widder, Joachim
    van der Heide, Uulke A.
    Schuring, Danny
    Senan, Suresh
    RADIATION ONCOLOGY, 2009, 4
  • [32] Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney
    Tan, Vivian S.
    Correa, Rohann J. M.
    Warner, Andrew
    Ali, Muhammad
    Muacevic, Alexander
    Ponsky, Lee
    Ellis, Rodney J.
    Lo, Simon S.
    Onishi, Hiroshi
    Swaminath, Anand
    Kwon, Young Suk
    Morgan, Scott C.
    Cury, Fabio L.
    Teh, Bin S.
    Mahadevan, Anand
    Kaplan, Irving D.
    Chu, William
    Hannan, Raquibul
    Staehler, Michael
    Zaorsky, Nicholas G.
    V. Louie, Alexander
    Siva, Shankar
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (06): : 1527 - 1534
  • [33] RECURRENCE, SURVIVAL, AND TOXICITY AFTER STEREOTACTIC LUNG RADIOTHERAPY (SBRT) FOR CENTRAL VERSUS PERIPHERAL STAGE I NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS FROM AN INTERNATIONAL COLLABORATIVE RESEARCH GROUP
    Grills, Inga S.
    Mangona, Victor S.
    Hope, Andrew
    Belderbos, Jose
    Werner-Wasik, Maria
    Sonke, Jan Jakob
    Bissonette, Jean-Pierre
    Ionascu, Dan
    Xiao, Ying
    Toussaint, Andre
    Guckenberger, Matthias
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S359 - S360
  • [34] QUALITY ASSURANCE OF 4D-CT SCAN TECHNIQUES IN MULTICENTER PHASE III TRIAL OF SURGERY VERSUS STEREOTACTIC RADIOTHERAPY (RADIOSURGERY OR SURGERY FOR OPERABLE EARLY STAGE (STAGE 1A) NON-SMALL-CELL LUNG CANCER [ROSEL] STUDY)
    Hurkmans, Coen W.
    van Lieshout, Maarten
    Schuring, Danny
    van Heumen, Marielle J. T.
    Cuijpers, Johan P.
    Lagerwaard, Frank J.
    Widder, Joachim
    van der Heide, Uulke A.
    Senan, Suresh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (03): : 918 - 927
1234